Article Text

Download PDFPDF
Letter
Diagnosing lung cancer earlier in the UK
  1. M Weir1,
  2. W J A Anderson1,2,
  3. Eoin Murtagh1,
  4. Ronan Donnelly1,
  5. Julian Leggett1,
  6. Jason Wieboldt3
  1. 1Department of Respiratory medicine, Antrim Area Hospital, UK
  2. 2School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, UK
  3. 3Department of Respiratory medicine, Causeway Hospital, UK
  1. Correspondence to Dr M Weir, Antrim Area Hospital, 45 Bush Rd, Antrim BT41 2RL, UK; mark79weir{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the article by Hubbard et al who raise late diagnosis as a key determinant of poor lung cancer survival in the UK.1 We would like to highlight discrepancies in rates of radical treatment use as another contributory factor. Figures from the Eurocare 4 study2 suggest 5-year survival figures in Northern Ireland have been higher than in England and Wales or Scotland (table 1).2–4 This could reflect differences in patient demographics, disease, method of recording or treatment modality. …

View Full Text

Footnotes

  • Linked articles 153064.

  • Competing interests None.

  • Provenance and peer review Not commissioned; not externally peer reviewed.

Linked Articles

  • PostScript
    Richard Hubbard David Baldwin